Category: Cost and Quality

They Tested Negative for Covid. Still, They Have Long Covid Symptoms.

Despite a negative covid test, people could have been infected with the coronavirus anyway. And some of them might face lingering health issues.

Scientists Seek Covid Treatment Answers in Cheap, Older Drugs

Philanthropies are funding studies of cheap, existing medications like the antidepressant fluvoxamine as covid treatments. But early hype about hydroxychloroquine and other repurposed drugs leaves researchers leery of hasty conclusions.

Military Exposed to Toxic Fumes From Burn Pits Set to Get Bipartisan Boost

Democratic Sen. Kirsten Gillibrand and Republican Sen. Marco Rubio were set to roll out a bill Friday that could help unknown thousands of service members who are sick from toxic substances they were exposed to from burning garbage in Afghanistan, Iraq and other war zones.

How One State’s Public Health Defunding Led to Vaccination Chaos

The underfunding of public health and political backlash destabilized Missouri’s vaccine rollout, creating racial inequity and forcing some residents to drive hours to get shots.

‘Incredibly Concerning’ Lawsuit Threatens No-Charge Preventive Care for Millions

A Texas federal judge, who previously ruled the Affordable Care Act unconstitutional, has signaled his openness to ending the law’s popular coverage requirement for preventive services.

Her Doctor’s Office Moved One Floor Up. Her Bill Was 10 Times Higher.

Same building. Same procedure. Same doctor. But now you’re charged a hospital facility fee. For one Ohio Medicare patient, the copay for a shot that used to cost her about $30 went up to more than $300.

Lots of Health Insurance Help in Covid Relief Law — But Do Your Homework First

Democrats’ $1.9 trillion covid relief package will offer some of the most significant help for Americans to pay for health insurance in a decade. But the temporary provisions are complicated. KHN offers tips for consumers.

Democrats Eye Medicare Negotiations to Lower Drug Prices

Progressive and conservative Democratic lawmakers, as well as President Joe Biden, are in favor of authorizing federal officials to negotiate with drugmakers over what Medicare pays for at least some of the most expensive brand-name drugs and to base those prices on the drugs’ clinical benefits. Such a measure could put Republicans in the uncomfortable position of opposing an idea that most voters from both parties generally support.

‘An Arm and a Leg’: In Vaccinating Philadelphia, A Mix of the Good, the Bad and the Ugly

Covid vaccinations are ramping up, so “An Arm and a Leg” checked in on the effort in Philadelphia, where capitalism and compassion have clashed.

‘An Arm and a Leg’: In Vaccinating Philadelphia, A Mix of the Good, the Bad and the Ugly

Covid vaccinations are ramping up, so “An Arm and a Leg” checked in on the effort in Philadelphia, where capitalism and compassion have clashed.